|
Addgene inc
human pegfp c2 nlrp3 plasmid Human Pegfp C2 Nlrp3 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human pegfp c2 nlrp3 plasmid/product/Addgene inc Average 93 stars, based on 1 article reviews
human pegfp c2 nlrp3 plasmid - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Addgene inc
cd63 rfp ![]() Cd63 Rfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd63 rfp/product/Addgene inc Average 95 stars, based on 1 article reviews
cd63 rfp - by Bioz Stars,
2026-03
95/100 stars
|
Buy from Supplier |
|
Addgene inc
pegfp c2 based gfp rhoc construct ![]() Pegfp C2 Based Gfp Rhoc Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pegfp c2 based gfp rhoc construct/product/Addgene inc Average 93 stars, based on 1 article reviews
pegfp c2 based gfp rhoc construct - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Addgene inc
pegfp c2 plasmid ![]() Pegfp C2 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pegfp c2 plasmid/product/Addgene inc Average 92 stars, based on 1 article reviews
pegfp c2 plasmid - by Bioz Stars,
2026-03
92/100 stars
|
Buy from Supplier |
|
Addgene inc
pegfp c2 sept9 i1 ![]() Pegfp C2 Sept9 I1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pegfp c2 sept9 i1/product/Addgene inc Average 92 stars, based on 1 article reviews
pegfp c2 sept9 i1 - by Bioz Stars,
2026-03
92/100 stars
|
Buy from Supplier |
|
Addgene inc
recombinant dna reagent pt2 cag ![]() Recombinant Dna Reagent Pt2 Cag, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/recombinant dna reagent pt2 cag/product/Addgene inc Average 94 stars, based on 1 article reviews
recombinant dna reagent pt2 cag - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
Addgene inc
gfp p53 ![]() Gfp P53, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/gfp p53/product/Addgene inc Average 93 stars, based on 1 article reviews
gfp p53 - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Addgene inc
plasmids encoding pegfp c2 senp2 ![]() Plasmids Encoding Pegfp C2 Senp2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/plasmids encoding pegfp c2 senp2/product/Addgene inc Average 91 stars, based on 1 article reviews
plasmids encoding pegfp c2 senp2 - by Bioz Stars,
2026-03
91/100 stars
|
Buy from Supplier |
|
Addgene inc
sqstm1 plasmid ![]() Sqstm1 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sqstm1 plasmid/product/Addgene inc Average 86 stars, based on 1 article reviews
sqstm1 plasmid - by Bioz Stars,
2026-03
86/100 stars
|
Buy from Supplier |
|
Cyagen Biosciences
plasmids encoding enhanced green fluorescent protein (pegfp)-c2-mir-126 sponge sequence ![]() Plasmids Encoding Enhanced Green Fluorescent Protein (Pegfp) C2 Mir 126 Sponge Sequence, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/plasmids encoding enhanced green fluorescent protein (pegfp)-c2-mir-126 sponge sequence/product/Cyagen Biosciences Average 90 stars, based on 1 article reviews
plasmids encoding enhanced green fluorescent protein (pegfp)-c2-mir-126 sponge sequence - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Qiagen
plasmid pegfp-asc-c2 ![]() Plasmid Pegfp Asc C2, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/plasmid pegfp-asc-c2/product/Qiagen Average 90 stars, based on 1 article reviews
plasmid pegfp-asc-c2 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
GenScript corporation
plasmid pegfp-c2- t17nrac1 ![]() Plasmid Pegfp C2 T17nrac1, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/plasmid pegfp-c2- t17nrac1/product/GenScript corporation Average 90 stars, based on 1 article reviews
plasmid pegfp-c2- t17nrac1 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: eLife
Article Title: The PMA phorbol ester tumor promoter increases canonical Wnt signaling via macropinocytosis
doi: 10.7554/eLife.89141
Figure Lengend Snippet:
Article Snippet: Recombinant DNA reagent ,
Techniques: Recombinant, Dominant Negative Mutation, Plasmid Preparation, Membrane, Luciferase, Expressing, Reporter Assay, Software, Imaging, Microinjection, Inverted Microscopy
Journal: bioRxiv
Article Title: Klebsiella pneumoniae reduces SUMOylation to limit host defence responses
doi: 10.1101/2020.06.29.179275
Figure Lengend Snippet: A. Immunoblot analysis of Ubc9 and tubulin levels in lysates of A549 cells infected with Kp52145 for the indicated times. Ubc9 bands were quantified from three independent experiments using Image Studio Lite (Li-cor) and the modification normalised to α-Tubulin. The graph represents fold change compared to non-infected control cells. n.s. – non significant; versus n.i. determined using one way-ANOVA with Tukey’s multiple comparisons test. B. Immunoblot analysis of Sae1, Sae2 and tubulin levels in lysates of A549 cells infected with Kp52145 for the indicated times. Sae1 and Sae2 bands were quantified from three independent experiments using Image Studio Lite (Li-cor) and the modification normalised to α-Tubulin. The graph represents fold change compared to non-infected control cells. n.s. – non significant; versus n.i. determined using one way-ANOVA with Tukey’s multiple comparisons test. C. Immunoblot analysis of SUMO1 and tubulin levels in lysates of control (AS), SENP1 or SENP2 siRNA-transfected A549 cells infected with Kp52145 for 5 h. AS-AllStars control, non-silencing siRNA. SUMO1 smears were quantified from three independent experiments using Image Studio Lite (Li-cor) and the modification normalised to α-Tubulin. The graph represents fold change compared to AS-transfected non-infected control cells. ***P ≤ 0.001; **P ≤ 0.01; *P ≤ 0.05; versus AS n.i. determined using one way-ANOVA with Bonferroni’s multiple comparisons test. D.Fluorescence microscopy of pSENP2-GFP transfected A549 cells grown on glass coverslips. Cells were infected with Kp52145 for 5 h or left uninfected (n.i.). Coverslips were stained with Hoechst (DAPI) for nuclei identification. The % of SENP2 localised in either nucleus or cytoplasm is represented on the graph and is the result of independent counting of 100 cells from each of 3 independent experiments. E.Immunoblot analysis of SENP2 and tubulin levels in cytosolic extracts of A549 cells infected with Kp52145 for 5 h or left uninfected (n.i.). F.Fluorescence microscopy of pSENP2-GFP transfected A549 cells grown on glass coverslips. Cells were treated with the proteasomal inhibitor MG262 (5 μM, 2 h before infection), the nuclear export inhibitor Leptomycin B (LMB, 10 nM, 2 h before infection) or DMSO (vehicle solution) and infected with Kp52145 for 5 h or left uninfected (n.i.). Coverslips were stained with Hoechst (DAPI) for nuclei identification. The % of SENP2 localized in either nucleus or cytoplasm is represented on the graphs and is the result of independent counting of 100 cells from each of 3 independent experiments. G.Immunoblot analysis of SUMO1 and tubulin levels in lysates of the nuclear export inhibitor Leptomycin B (LMB, 5 μM, 2 h before infection) or DMSO (vehicle solution)-treated A549 infected with Kp52145 for 5 h or left uninfected (n.i.). SUMO1 smears were quantified using Image Studio Lite (Li-cor) and the modification normalised to α-Tubulin. The graph represents fold change compared to DMSO non-infected control cells. **P ≤ 0.01 versus DMSO n.i. determined using one way-ANOVA with Bonferroni’s multiple comparisons test. H.Immunoblot analysis of K48-linkage specific polyubiquitin and FLAG (DYKDDDDK-protein tag) levels in immunoprecipitates of A549 infected with Kp52145 for 5 h. Cells were immunoprecipitated using anti-FLAG antibody. Preimmune mouse IgG served as negative control. I.Immunoblot analysis of SENP2 and tubulin levels in cytosolic extracts of control (AS), Rbx1, Skp1, Cul-1, βTrCP or Skp2 siRNA-transfected A549 cells left uninfected (n.i.). J.Immunoblot analysis of Cullin-1 and tubulin levels in lysates of A549 cells infected with Kp52145 for 5 h or left uninfected (n.i.). Lysates of A549 treated with 5 mM of H 2 O 2 for 10 min were used as a positive control for Cullin-1 deNEDDylation. K.Immunoblot analysis of Cullin-1 and tubulin levels in lysates of control (AS) or CSN5 siRNA-transfected A549 cells infected with Kp52145 for 5 h or left uninfected (n.i.). AS-AllStars control, non-silencing siRNA. L.Immunoblot analysis of K48-linkage specific polyubiquitin and FLAG (DYKDDDDK-protein tag) levels in immunoprecipitates of control (AS) or CSN5 siRNA-transfected A549. Cells were transfected with a SENP2-FLAG plasmid 24 h after the siRNA transfection and infected the following day with Kp52145 for 5 h or left uninfected. Cells were immunoprecipitated using anti-FLAG antibody. Preimmune mouse IgG served as negative control. M.Immunoblot analysis of Senp2 and tubulin levels in cytosolic extracts of control (AS) or CSN5 siRNA-transfected A549 cells infected with Kp52145 for 5 h or left uninfected (n.i.). AS-AllStars control, non-silencing siRNA. N.Immunoblot analysis of SUMO1 and tubulin levels in lysates of control (AS) or CSN5 siRNA-transfected A549 cells infected with Kp52145 for 5 h or left uninfected (n.i.). AS-AllStars control, non-silencing siRNA. SUMO1 smears were quantified from three independent experiments using Image Studio Lite (Li-cor) and the modification normalised to α-Tubulin. The graph represents fold change compared to AS-transfected non-infected control cells. **P ≤ 0.01 versus AS n.i. determined using one way-ANOVA with Bonferroni’s multiple comparisons test. In all panels data are representative of at least three independent experiments.
Article Snippet: Cells were transfected using Lipofectamine 2000 with
Techniques: Western Blot, Infection, Modification, Control, Transfection, Fluorescence, Microscopy, Staining, Immunoprecipitation, Negative Control, Positive Control, Plasmid Preparation
Journal: bioRxiv
Article Title: Klebsiella pneumoniae reduces SUMOylation to limit host defence responses
doi: 10.1101/2020.06.29.179275
Figure Lengend Snippet: A. ELISA of IL-8 secreted by A549 cells transfected with either empty control plasmid (pcDNA3) or SUMO1-HA tagged plasmid (pSUMO1), which were left untreated (n.i.) or infected with Kp52145 for 3 h of contact after which the medium was replaced with medium containing gentamicin (100 µg mL -1 ) to kill extracellular bacteria and incubated for a further 4 hours. Values are presented as the mean ± SD of three independent experiments measured in duplicate. ***P ≤ 0.001; *P ≤ 0.05; versus pcDNA3 determined using two way-ANOVA with Holm-Sidak’s multiple comparisons test. B. ELISA of IL-8 secreted by control (AS) or Senp2 siRNA-transfected A549, which were left untreated (n.i.) or infected with Kp52145 for 3 h of contact after which the medium was replaced with medium containing gentamicin (100 µg mL -1 ) to kill extracellular bacteria and incubated for a further 4 hours. Values are presented as the mean ± SD of three independent experiments measured in duplicate. ***P ≤ 0.001; *P ≤ 0.05; versus AS determined using two way-ANOVA with Holm-Sidak’s multiple comparisons test. C.ELISA of TNFα secreted by empty control (pcDNA3) or SUMO1-HA plasmid-transfected MH-S, which were left untreated (n.i.) or infected with Kp52145 for 1 h of contact after which the medium was replaced with medium containing gentamicin (100 µg mL -1 ) to kill extracellular bacteria and incubated for a further 4 hours. Values are presented as the mean ± SD of three independent experiments measured in duplicate. ***P ≤ 0.001; *P ≤ 0.05; versus pcDNA3 determined using two way-ANOVA with Holm-Sidak’s multiple comparisons test. D.ELISA of TNFα secreted by antagomir-transfected MH-S, which were left untreated (n.i.) or infected with Kp52145 for 1 h of contact after which the medium was replaced with medium containing gentamicin (100 µg mL -1 ) to kill extracellular bacteria and incubated for a further 4 hours. Values are presented as the mean ± SD of three independent experiments measured in duplicate. ***P ≤ 0.001; *P ≤ 0.05; versus Negative Kp52145 determined using two way-ANOVA with Holm-Sidak’s multiple comparisons test. E.Immunoblot analysis of IκBα and tubulin levels in lysates of empty (pcDNA3) or SUMO1-HA (pSUMO1) plasmid transfected A549 or MH-S cells, infected with Kp52145 for the indicated time points. F.Immunoblot analysis of JNK (P-JNK), ERK (P-ERK) and p38 (P-p38) phosphorylation levels in lysates of empty (pcDNA3) or SUMO1-HA (pSUMO1) plasmid transfected A549 or MH-S cells, infected with Kp52145 for the indicated time points. Tubulin immunoblotting was used as the loading control. n.i. – non-infected control G.ELISA of IL-8 or TNFα secreted by empty control (pcDNA3) or SUMO1-HA plasmid-transfected A549 or MH-S respectively, which were treated with the NF-κB inhibitor BAY 11-7082 (5 μM, 2 h before infection) or DMSO (vehicle solution). Cells were left untreated (n.i.) or infected with Kp52145 for 1 h (MH-S) or 3 h (A549) of contact after which the medium was replaced with medium containing gentamicin (100 µg mL -1 ) to kill extracellular bacteria and incubated for a further 4 hours. Values are presented as the mean ± SD of three independent experiments measured in duplicate. ***P ≤ 0.001; *P ≤ 0.05; determined using two way-ANOVA with Holm-Sidak’s multiple comparisons test. H.Percentage of intracellular survival in MH-S cells transfected with either empty control plasmid (pcDNA3) or SUMO1-HA tagged plasmid (pSUMO1). Cells were infected with Kp52145 for 30 min (MOI 100:1), wells were washed and incubated with medium containing gentamicin (100 μg mL -1 ) for 2.5 h. Intracellular bacteria were quantified by lysis, serial dilution and viable counting on LB agar plates. Percentage of intracellular survival was determined by dividing the number of colony forming units (CFU) obtained at 3 h of infection over the number obtained at 1 h and considering pcDNA3 as 100 %. Values are presented as the mean ± SD of three independent experiments measured in duplicate. ***P ≤ 0.001; *P ≤ 0.05; versus pcDNA3 determined using unpaired t-test with correction for Holm-Sidak’s multiple comparisons test. I.Percentage of intracellular survival in antagomir transfected MH-S cells. Cells were infected with Kp52145 for 30 min (MOI 100:1), wells were washed and incubated with medium containing gentamicin (100 μg mL -1 ) for 2.5 h. Intracellular bacteria were quantified by lysis, serial dilution and viable counting on LB agar plates. Percentage of intracellular survival was determined by dividing the number of colony forming units (CFU) obtained at 3 h of infection over the number obtained at 1 h and considering the negative control as 100 %. Values are presented as the mean ± SD of three independent experiments measured in duplicate. **P ≤ 0.01; *P ≤ 0.05; versus negative control determined using one way-ANOVA with Holm-Sidak’s multiple comparisons test. In panels E and F, data are representative of at least three independent experiments.
Article Snippet: Cells were transfected using Lipofectamine 2000 with
Techniques: Enzyme-linked Immunosorbent Assay, Transfection, Control, Plasmid Preparation, Infection, Bacteria, Incubation, Western Blot, Phospho-proteomics, Lysis, Serial Dilution, Negative Control
Journal: bioRxiv
Article Title: Klebsiella pneumoniae reduces SUMOylation to limit host defence responses
doi: 10.1101/2020.06.29.179275
Figure Lengend Snippet: Working model of K. pneumoniae strategies to decrease SUMOylation in epithelial cells and macrophages. In epithelial cells, Kp52145 activates the signalling pathway EGFR-PI3K-AKT-ERK-GSK3β to increase the COP9 signalosome component CSN5 which inhibits NEDDylation of Cullin-1 and prevents proteasomal degradation of SENP2. SENP2 then accumulates in the cytosol preventing SUMOylation. In macrophages, Kp52145 via TLR4-TRAM-TRIF induces the production of type-I interferon, which signals through the IFNAR1 receptor. Type-I interferon stimulates transcription of the miRNA let-7 which prevents SUMOylation. Both strategies lead to increased intracellular survival and subversion of host responses.
Article Snippet: Cells were transfected using Lipofectamine 2000 with
Techniques:
Journal: Oncogene
Article Title: MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability
doi: 10.1038/onc.2017.193
Figure Lengend Snippet: miR-20a targets several autophagy related genes. ( a ) Relative mRNA levels (normalized by GAPDH) of BECN1, SQSTM1, ATG16L1 in MCF7 or ( c ) MDA-MB-231 cells overexpressing NC or miR-20a were analyzed by qPCR. ( b ) MCF7 or ( d ) MDA-MB-231 cells transfected with NC, miR-20a, LNA-NC or LNA-20a were either untreated or treated with EBSS for 4 h. The protein levels of ATG16L1, BECN1 and SQSTM1 were analyzed by immunoblotting. ( e ) Schematic illustration of the predicted miR-20a pairing sites in BECN1, SQSTM1 and ATG16L1 3′UTRs. Luciferase reporters containing wild type (WT) or mutated (MUT) BECN1, SQSTM1 or ATG16L1 3′UTR fragments were co-transfected with NC or miR-20a into MCF7 cells. Relative luciferase activity was normalized to NC (** P <0.01).
Article Snippet:
Techniques: Transfection, Western Blot, Luciferase, Activity Assay
Journal: Oncogene
Article Title: MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability
doi: 10.1038/onc.2017.193
Figure Lengend Snippet: miR-20a increases intracellular ROS levels and DNA damage. ( a ) Immunofluorescence of γH2AX in MCF7 cells overexpressing NC or miR-20a, γH2AX fluorescence intensity was quantified with Image J software (*** P <0.001). ( b ) Protein expression of γH2AX and GAPDH were detected by immunoblotting in MCF7 cells overexpressing miRNAs or LNA inhibitors. ( c ) Comet assay in MCF7 cells overexpressing NC or miR-20a. Tail moment (TM) of at least 50 cells in three independent experiments were analyzed by the specific software CASP (** P <0.01). ( d ) MCF7 cells overexpressing miRNAs or siRNAs were cultured in normal medium or EBSS medium for 4 h. Intracellular ROS levels were determined by Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit. ( e ) The expression levels of γH2AX, BECN1, SQSTM1, ATG16L1, LC3 and ACTB in MCF7 cells transfected with siRNAs were determined by western blotting. ( f ) Relative γH2AX protein expression (normalized by ACTB) was determined by Image J densitometric analysis. ( g ) DQ Red BSA fluorescence intensity in MCF7 cells transfected with siRNAs against ATG16L1, BECN1 or SQSTM1 (* P <0.05, ** P <0.01). ( h ) miR-20a and plasmids (BECN1-GFP, FLAG-ATG16L1, HA-SQSTM1) were co-transfected into MCF7 cells, cells were cultured in normal medium or EBSS medium for 4 h, samples were collected for immunoblotting analysis. ( i ) Relative γH2AX protein expression (normalized by ACTB) was determined by Image J densitometric analysis. ( j ) Proteolytic activity was analyzed in MCF7 cells expressing miR-20a and plasmids (* P <0.05).
Article Snippet:
Techniques: Immunofluorescence, Fluorescence, Software, Expressing, Western Blot, Single Cell Gel Electrophoresis, Cell Culture, Transfection, Activity Assay
Journal: Oncogene
Article Title: MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability
doi: 10.1038/onc.2017.193
Figure Lengend Snippet: Expression of miR-20a and its target genes in breast cancer specimens. ( a ) Expression of miR-20a in normal breast ( n =30) and breast tumor tissues ( n =30) was determined by in situ hybridization. ( b ) miRNA in situ hybridization and HE staining in tissues from a triple-negative breast cancer patient. ( c ) Immunohistochemical analysis of γH2AX, BECN1, SQSTM1 and ATG16L1 in triple-negative breast cancer tissues and adjacent normal tissues. ( d ) Immunoblotting analysis of SQSTM1, ATG16L1, BECN1 and OPTN in normal mammary tissues and triple-negative breast cancer tissues. Densitometric ratios of BCEN1, SQSTM1, OPTN and ATG16L1 versus ACTB were quantified by Image J software.
Article Snippet:
Techniques: Expressing, In Situ Hybridization, Staining, Immunohistochemical staining, Western Blot, Software
Journal: Oncogene
Article Title: MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability
doi: 10.1038/onc.2017.193
Figure Lengend Snippet: Higher expression of miR-20a is associated with downregulation of BECN1 , ATG16L1 and SQSTM1 . ( a ) Correlation between miR-20a and BECN1, SQSTM1, and ATG16L1 was determined using Spearman coefficient analysis in TCGA breast cancer samples ( n =500). ( b ) The expression of BECN1, SQSTM1 and ATG16L1 in triple-negative breast cancers ( n =82) and other subtypes ( n =391).
Article Snippet:
Techniques: Expressing
Journal: Oncogene
Article Title: MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability
doi: 10.1038/onc.2017.193
Figure Lengend Snippet: miR-20a promotes tumorigenesis in a xenograft mouse model. ( a ) Genomic instability (fraction of copy-number altered genome and mutation counts) was detected in TCGA breast cancer patients ( P <0.001, n =347). ( b ) MDA-MB-231 cells stably expressing NC or miR-20a were injected into nude mice. miR-20a promotes tumorigenesis compared with NC at day 8 of injection. ( c ) miR-20a promotes tumor growth in vivo . Tumor growth curve was determined by measuring the width and length every day (* P <0.05, ** P <0.01, *** P <0.001). ( d ) Oncogenic miR-20a directly targets ATG16L1, BECN1 and SQSTM1, inhibits autophagic flux and lysosomal proteolytic activity, increases ROS levels and accumulates DNA damage, which likely contribute to genome instability and tumor-initiating capacity.
Article Snippet:
Techniques: Mutagenesis, Stable Transfection, Expressing, Injection, In Vivo, Activity Assay